BioHarvest Sciences Inc.
BHST
$6.55
-$0.05-0.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.28M | 6.54M | 6.03M | 5.34M | 4.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.28M | 6.54M | 6.03M | 5.34M | 4.52M |
| Cost of Revenue | 3.16M | 2.83M | 2.93M | 2.34M | 2.23M |
| Gross Profit | 4.12M | 3.71M | 3.10M | 3.00M | 2.29M |
| SG&A Expenses | 4.41M | 4.54M | 3.79M | 3.39M | 3.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.97M | 8.64M | 7.80M | 6.77M | 7.07M |
| Operating Income | -1.69M | -2.10M | -1.78M | -1.42M | -2.55M |
| Income Before Tax | -2.95M | -2.69M | -687.00K | -6.58M | -7.24M |
| Income Tax Expenses | 8.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.96M | -2.69M | -687.00K | -6.58M | -7.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.96M | -2.69M | -687.00K | -6.58M | -7.24M |
| EBIT | -1.69M | -2.10M | -1.78M | -1.42M | -2.55M |
| EBITDA | -1.57M | -1.75M | -1.42M | -1.22M | -2.45M |
| EPS Basic | -0.17 | -0.16 | -0.04 | -0.48 | -0.52 |
| Normalized Basic EPS | -0.11 | -0.10 | -0.03 | -0.30 | -0.32 |
| EPS Diluted | -0.17 | -0.16 | -0.04 | -0.48 | -0.52 |
| Normalized Diluted EPS | -0.11 | -0.10 | -0.03 | -0.30 | -0.32 |
| Average Basic Shares Outstanding | 17.34M | 17.34M | 16.35M | 13.75M | 14.04M |
| Average Diluted Shares Outstanding | 17.34M | 17.34M | 16.35M | 13.75M | 14.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |